TrialThe Journal of urology2016

The Association between Phosphodiesterase Type 5 Inhibitors and Prostate Cancer: Results from the REDUCE Study.

Juzar Jamnagerwalla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.